Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review.
Renate Ilona HausingerQuirin BachmannTimotius Crone-RaweNora HannaneIna MonsefBernhard HallerUwe HeemannNicole SkoetzNina KreuzbergerChristoph SchmadererPublished in: Vaccines (2023)
Additional SARS-CoV-2 vaccine doses are potent and safe in general terms as well as regarding transplant-specific outcomes whilst the Omicron wave remains a significant threat to KTRs without adequate immune responses.